MedTech Acquisition Corporation (MTAC)
| Market Cap | 83.59M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 5.54M |
| Shares Out | 8.20M |
| EPS (ttm) | 0.19 |
| PE Ratio | 53.63 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 250 |
| Open | 10.19 |
| Previous Close | 10.28 |
| Day's Range | 10.19 - 10.20 |
| 52-Week Range | 9.78 - 10.68 |
| Beta | -0.03 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About MTAC
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut. [Read more]
Financial Performance
Financial StatementsNews
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business
DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Busi...
TriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology™-01 and -02 Studies
DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc.
TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) Clinical Trial Progress and Pre-clinical Research Developments
DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Bu...
MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders
The Company recommends all of its stockholders to vote FOR the Extension Amendment at the upcoming Special Meeting.
TriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical Studies
TriSalus Life Sciences®, Inc. (“TriSalus”) (the “Company”), an oncology therapeutics company in the process of going public through a business combination transaction (the “Business Combination”) with...
TriSalus Life Sciences to Become Publicly Traded Through Merger With MedTech Acquisition Corporation
DENVER & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--TriSalus Life Sciences® (the “Company” or “TriSalus”), a privately held oncology therapeutics company integrating immunotherapy with disruptive deliv...
MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination
TEL AVIV, Israel and FORT LAUDERDALE, Fla., March 10, 2022 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech”), a publicly traded special purpose acquisition company (SPAC) ...
Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021
TEL AVIV, Israel and FORT LAUDERDALE, Fla., Jan. 6, 2022 /PRNewswire/ -- Memic Innovative Surgery Ltd.
Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation
TEL AVIV, Israel and FORT LAUDERDALE, Fla., Sept. 9, 2021 /PRNewswire/ -- Memic Innovative Surgery Ltd.
Peregrine Ventures Portfolio Company Memic Announces $1B Valuation SPAC deal
OR YEHUDA, Israel, Aug. 19, 2021 /PRNewswire/ -- Peregrine Ventures portfolio company Memic Innovative Surgery Ltd. has entered into a definitive agreement for a business combination with MedTech Acqu...
Memic Going Public Via SPAC: What Investors Should Know About This Medical Device Company
A SPAC led by the founder of Memic Innovative Surgery and several experienced medical device company executives has announced its merger partner. The SPAC Deal: Memic Innovative Surgery announced a S...
Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination
TEL AVIV, Israel and FORT LAUDERDALE, Fla., Aug. 13, 2021 /PRNewswire/ -- Memic Innovative Surgery Ltd.
MedTech Acquisition Corporation Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
New York, NY, June 02, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq: MTACU) (the “Company”) today announced that it has received a notice (“Notice”) from the Listing Qualifications...
MedTech Acquisition Corporation Announces Separate Trading of its Class A Common Stock and Warrants, Commencing February 8, 2021
New York, NY, Feb. 05, 2021 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (Nasdaq:MTACU) (the “Company”) announced today that, commencing February 8, 2021, holders of the 25,000,000 units sold i...
MedTech Acquisition Corporation Announces Closing of Upsized $250,000,000 Initial Public Offering
New York, NY, Dec. 22, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it closed its initial public offering of 25,000,000 units, which included 3,000,000...
MedTech Acquisition Corporation Announces Pricing of Upsized $220,000,000 Initial Public Offering
New York, NY, Dec. 17, 2020 (GLOBE NEWSWIRE) -- MedTech Acquisition Corporation (the “Company”) announced today that it priced its upsized initial public offering of 22,000,000 units at $10.00 per uni...